BioLattice addresses the need for tissue healing solutions.
BioLattice has raised $575K in total funding. The most recent round was Seed. The last funding was announced in March 2026.
BioLattice's investors include SOSV, SOSV SF & NY (Fka IndieBio), Startup302.
BioLattice is headquartered in Philadelphia, United States.
BioLattice addresses the need for tissue healing solutions.
BioLattice is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioLattice — Funding & Investors." VCBacked, March 30, 2026, https://www.vcbacked.co/company/biolattice. Accessed August 14, 2026.
VCBacked. (2026). BioLattice — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/biolattice
{{cite web |title=BioLattice — Funding & Investors |url=https://www.vcbacked.co/company/biolattice |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated